More on Becton, Dickinson FQ1: Net profit falls; raises outlook

Becton, Dickinson (BDX) FQ1 net profit falls to $271M from $625M a year earlier, which included income of $355M from discontinued operations.

Total operating costs +8.5% to $1.64B.

Revenue breakdown: Medical segment +8.2% to $1.06B, Diagnostics +3.1% to $672M. U.S revenues +2.3%, international +8.9%, reflecting strength in emerging markets.

BD raises the lower end of its FY adjusted EPS guidance by 3 cents and now expects $6.19-6.22 vs $5.81 a year earlier. Consensus is for $6.23. BD projects that reported and currency-neutral revenues will increase 4.5-5% vs a previous prediction of +4-5%.

BD intends to buy back $450M of its common stock during the FY. (PR)


From other sites
Comments (1)
  • Doug Meeks
    , contributor
    Comments (1934) | Send Message
    The net profit drop was expected. The EPS was above expectations, and revenue was above expectations, so last year BDX had a big business unit sale to add to the bottom line pushing it up on a one time item to $625M, this is a poorly written post on what is ALL GOOD NEWS FROM BDX.
    4 Feb 2014, 08:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs